Prostate Cancer - Local Treatment After Radiorecurrence: Salvage Cryoablation

Overview

Journal Int Braz J Urol

Specialty Urology

Date 2018 May 25

PMID 29792652

Citations 4

Authors

Rodrigo Donalisio da Silva

Fernando J Kim

Affiliations

Soon will be listed here.

Citing Articles

The Role of Whole-Gland and Focal Cryotherapy in Recurrent Prostate Cancer.

Pio F, Murdock A, Fuller R, Whalen M Cancers (Basel). 2024; 16(18).

PMID: 39335196 PMC: 11430134. DOI: 10.3390/cancers16183225.

Transperineal Laser Ablation (TPLA) Treatment of Focal Low-Intermediate Risk Prostate Cancer.

Manenti G, Perretta T, Nezzo M, Fraioli F, Carreri B, Gigliotti P Cancers (Basel). 2024; 16(7).

PMID: 38611082 PMC: 11011049. DOI: 10.3390/cancers16071404.

Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.

Manenti G, Nezzo M, Ryan C, Fraioli F, Carreri B, Gigliotti P BJR Open. 2023; 5(1):20230042.

PMID: 37942495 PMC: 10630978. DOI: 10.1259/bjro.20230042.

Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes.

Lewin R, Amit U, Laufer M, Berger R, Dotan Z, Domachevsky L Radiat Oncol. 2021; 16(1):114.

PMID: 34162398 PMC: 8220691. DOI: 10.1186/s13014-021-01839-w.

References

da Silva R, Kim F . Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer. Int Braz J Urol. 2015; 41(1):5-9. PMC: 4752050. DOI: 10.1590/S1677-5538.IBJU.2015.01.02. View

Agarwal P, Sadetsky N, Konety B, Resnick M, Carroll P . Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2007; 112(2):307-14. DOI: 10.1002/cncr.23161. View

Huang W, Lee C, Eastham J . Locally ablative therapies for primary radiation failures: a review and critical assessment of the efficacy. Curr Urol Rep. 2007; 8(3):217-23. DOI: 10.1007/s11934-007-0009-5. View

Smit Duijzentkunst D, Peters M, van der Voort van Zyp J, Moerland M, van Vulpen M . Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review. World J Urol. 2016; 34(11):1521-1531. PMC: 5063906. DOI: 10.1007/s00345-016-1811-9. View

Miano R, Asimakopoulos A, da Silva R, Bove P, Jones S, de la Rosette J . Focal therapy for prostate cancer: current status and future perspectives. Minerva Urol Nefrol. 2015; 67(3):263-80. View

Miano R, De Nunzio C, Kim F, Rocco B, Gontero P, Vicentini C . Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study. Int Braz J Urol. 2014; 40(1):16-22. DOI: 10.1590/S1677-5538.IBJU.2014.01.03. View

Zumsteg Z, Spratt D, Romesser P, Pei X, Zhang Z, Polkinghorn W . The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol. 2014; 67(6):1009-1016. PMC: 5002994. DOI: 10.1016/j.eururo.2014.09.028. View

Finley D, Pouliot F, Miller D, Belldegrun A . Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010; 37(1):67-82, Table of Contents. DOI: 10.1016/j.ucl.2009.11.007. View

Levy D, Li J, Stephen Jones J . Disease burden predicts for favorable post salvage cryoablation PSA. Urology. 2010; 76(5):1157-61. DOI: 10.1016/j.urology.2010.01.053. View

10.

Spiess P, Levy D, Mouraviev V, Pisters L, Stephen Jones J . Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. BJU Int. 2013; 112(4):E256-61. DOI: 10.1111/j.1464-410X.2012.11695.x. View

11.

Mouraviev V, Spiess P, Stephen Jones J . Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy. Eur Urol. 2012; 61(6):1204-11. DOI: 10.1016/j.eururo.2012.02.051. View

12.

Kimura M, Mouraviev V, Tsivian M, Mayes J, Satoh T, Polascik T . Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2009; 105(2):191-201. DOI: 10.1111/j.1464-410X.2009.08715.x. View

13.

Pisters L, Rewcastle J, Donnelly B, Lugnani F, Katz A, Stephen Jones J . Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008; 180(2):559-63. DOI: 10.1016/j.juro.2008.04.005. View

14.

De Castro Abreu A, Bahn D, Leslie S, Shoji S, Silverman P, Desai M . Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013; 112(3):298-307. DOI: 10.1111/bju.12151. View

15.

Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby G, Katz A . Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol. 2010; 24(7):1123-9. DOI: 10.1089/end.2010.0130. View

16.

da Silva R, Jaworski P, Gustafson D, Nogueira L, Molina W, Kim F . How I do it: prostate cryoablation (PCry). Can J Urol. 2014; 21(2):7251-4. View

17.

Miano R, Kim F, De Nunzio C, Mauriello A, Sansalone S, Vespasiani G . Morphological evaluation of the male external urethral sphincter complex by transrectal ultrasound: feasibility study and potential clinical applications. Urol Int. 2012; 89(3):275-82. DOI: 10.1159/000339716. View

18.

Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M . Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys. 2000; 48(2):355-67. DOI: 10.1016/s0360-3016(00)00637-4. View